A pilot study of neoadjuvant olaparib for patients with HRD-positive advanced ovarian cancer

Harano, K; Nakao, T; Nishio, S; Katsuda, T; Tasaki, K; Takehara, K; Yokoyama, T; Furuya, H; Hongo, K; Asano, M; Ikeno, T; Wakabayashi, M; Sato, A; Tanabe, H; Taki, T; Watanabe, R; Ishii, G; Mukohara, T

ANNALS OF ONCOLOGY, 2022; 33 (7): S792